Email Page Print Page

Employment Opportunities

Head of Business Development


The Head of Business Development will be responsible for activities supporting the in-licensing of products and/or companies, the out-licensing or partnering of BDSI products to companies both within and outside the U.S., and co-promotions. The position will support the future growth of BDSI through product/company acquisitions and securing of external commercial and/or development partners or co-promotion partners when needed. It will include seeking out opportunities, providing a thorough analysis and marketing research to support decision making, and executing the licensing process. Strong analytical skills and experience in the pharmaceutical industry is necessary, as well as the ability to work closely with cross functional teams internally and external partner candidates. Experience in Business Development and a past history of successful business development transactions in pharmaceuticals are critical. The position will work closely with BDSI Senior Management as well as R&D, Clinical, Regulatory, Legal, Finance and Commercial functions in the assessment and decision making process, conduct of due diligence and execution of agreements.  The position will report to the Senior Vice President, Corporate and Business Development.


Serves as a key point of contact within BDSI for potential licensing, acquisition, collaborations, and co-promotion agreements.
Leads efforts in the search, evaluation, due diligence and execution of business development opportunities.
Coordinates and manages the assessment and review process for all opportunities identified including data analysis, marketing research when needed, and forecasting.
Works closely with R&D, Clinical, Regulatory, Legal, Commercial and Finance to ensure deals are being advanced and executed.
Responsible for the quality of the formal due diligence output, integrating internal and external subject matter, and expert input for senior management review and approval.
Assures appropriate deal structure, terms, financial models and value creation.
Proposes measures to improve internal processes to assure optimal evaluation of potential targets and opportunities.


Good understanding of industry trends and competitive landscape, ideally with some experience in the pain, addiction and CNS area.
Strong business acumen and ability to translate scientific and technical information to identify attractive business opportunities.
Strong interpersonal, analytical, critical-thinking, verbal and written communication skills.
Strong leadership skills and proven ability to influence others to reach common goals as well as act independently.
Adaptable to change and a willingness to contribute to the overall business as needed.
Demonstrated ability to manage resources and find creative means to gather the information needed to support decision making.
Solid negotiation skills.


BA or BS required, MBA preferred
Minimum 8-10 years of experience working for a pharmaceutical/biotech company in business development, licensing, or strategic analysis capacities or experience working for a consulting firm or investment bank focused on the pharmaceutical/biotech markets with additional pharmaceutical/biotech industry experience.
Track record of successfully executing deals from start-to-finish within prior biotech/pharma positions.
Possess superior analytical, strategic and communication skills. Well organized and detail oriented. Advanced knowledge of data and custom research methodologies to support decision making.
Analytical reasoning abilities, strong business acumen, and creativity in problem solving.
Strong verbal and written communication skills as well as presentation skills with the ability to interact effectively with/present to (verbally and in writing) all levels of the organization.
Ability to manage multiple projects and meet required deadlines.


Upload your resume. Please use only WORD or PDF documents.
Enter Text Above:

Can't Read It?
Click Below

Get the latest details on our products and services.

Top News

BioDelivery Sciences Announces Preferred Formulary Status for BUNAVAIL on Texas Medicaid
BUNAVAIL moved from non-formulary to preferred status

BioDelivery Sciences Announces Additions to its Board of Directors
Timothy C. Tyson joins BDSI's board as an independent member with over 30 years of pharmaceutical experience

BioDelivery Sciences Cites Impressive Number of Physicians Granted Waiver to Increase Patient Limit for Opioid Dependence Treatment Following Recent HHS Rule
SAMHSA Reports 1,665 Clinicians Granted Waivers at the Increased Limit as of This Week

BioDelivery Sciences to Present at the Ladenburg Thalmann 2016 Healthcare Conference

BioDelivery Sciences Announces Three New Managed Care Agreements; Further Enhancing Access to BUNAVAIL
New contracts improve BUNAVAIL formulary status and give BUNAVAIL access to approximately 200,000 additional prescriptions for buprenorphine products for opioid dependence annually